Skip to content

Reduction of Breast Hypertrophy by Means of Coelioscopique Surgery

Reduction of Breast Hypertrophy by Means of Coelioscopique Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05822115
Acronym
R-HTM-R
Enrollment
5
Registered
2023-04-20
Start date
2023-04-24
Completion date
2024-09-30
Last updated
2023-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reduction

Brief summary

The objective of this interventional study is based on the hypothesis that coelioscopique surgery could be used to reduce breast hypertrophy. This study can be expected to scientifically validate the use of laparoscopic surgery to obtain a clinical result in the context of reduction of medium volume breast hypertrophy.

Detailed description

Breast reductions are common procedures. One of the main difficulties related to this surgery remains the healing, wide at the peri-areolar level, vertical at the sub-areolar level and in the sub-mammary fold. In addition, this intervention remains subject to the vagaries of hypertrophic or even keloidal healing, especially in young subjects. On This study can be expected to scientifically validate the use of laparoscopic surgery to obtain a clinical result without scarring in the context of the reduction of medium volume breast hypertrophy. Ultimately, the results of this study may serve as a basis for further research by proposing: * Prophylactic mastectomies and immediate breast reconstruction without lateral scar and with a less visible sub-breast scar. * A breast reduction in young patients before the skin undergoes the effects of the heaviness of the breasts.

Interventions

DEVICEReduction of breast hypertrophy by means of laparoscopic

The research procedure is a breast reduction performed by means of laparoscopic surgery. The project consists of removing a disc from the breast at the level of the base, thus causing peripheral skin slackening of 2 to 3 cm but circular. Both breasts are usually operated on at the same time. In case of asymmetry, only one side will be treated.

Sponsors

Groupe Hospitalier Nord-Essonne
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

: * Women over the age of 18. * Category 1 or 2 according to the Regnault classification. * C cup breast size or larger. * Areola looks ahead i.e. a distance between point A (at the top of the areola) at the median suprasternal point of approximately 16 cm to 24 cm. * Ptosis (distance between the lowest part of the breast and the submammary fold) of a maximum of 7cm (measured in a seated position). * Expected correction of half ptosis with decrease of 1 to 3 cup sizes. * Patient has good quality thick skin. * Social security scheme. * Patient requesting breast reduction. * Patient having signed the free and informed consent. Non inclusion criteria : * Areola look down; point A more than 25 cm. * Ptosis greater than or equal to 8 cm. * Thin skin. * Smoker. * Patient under effects of anti-coagulant. * Patient participating in another clinical study. * Protected patient: adults under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision. * Pregnant, lactating woman.

Design outcomes

Primary

MeasureTime frameDescription
Photography of the scarat 3 monthscentimeter

Secondary

MeasureTime frameDescription
Resection weightat 0 dayResection weight
Photography of Areolaat 3 weeks, 3 months and 1 yearCentimeter
Scar lenghtat 3 weeks, 3 months and 1 yearCentimeter
Blood lossat 1 daythe haemoglobin (hb) level
Scar assessmentat 3 weeksnumber of scars
Satisfaction scaleat 3 weeks, 3 months and 1 year0 (dissatisfied) to 10 (satisfied)
Cancerat day 0presence or absence
Macroeconomic impactat 1 yearlength of hospital stay, duration of surgery
Scar thicknessat 3 weeks, 3 months and 1 yearCentimeter
Pain scaleat 3 weeks, 3 months and 1 year0 (no pain) to 10 (very intense pain)

Countries

France

Contacts

Primary ContactEric Dr DUNET, Chirurgien
ericdunet@gmail.com+33607812501
Backup ContactJérôme Mr KOZLOWSKI, Directeur Innovation Recherche
n.goumas@ghne.fr+33664542963

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026